Cargando…
Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease
BACKGROUND: Patients with IBD and chronic inflammation refractory to conventional therapy often demonstrate higher risk of serious complications. Combinations of immunosuppression and biological treatment as well as surgical intervention are often used in this patient group. Hence, there is need for...
Autores principales: | Lindberg, Annelie, Eberhardson, Michael, Karlsson, Mats, Karlén, Per |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914086/ https://www.ncbi.nlm.nih.gov/pubmed/20604939 http://dx.doi.org/10.1186/1471-230X-10-73 |
Ejemplares similares
-
CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD
por: Linton, Ludvig, et al.
Publicado: (2011) -
Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
por: Chen, Xiu-Li, et al.
Publicado: (2020) -
HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD
por: Linton, Ludvig, et al.
Publicado: (2012) -
Granulocyte and monocyte adsorptive apheresis ameliorates sepsis in rats
por: Ma, Shuai, et al.
Publicado: (2017) -
Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)
por: Gnesotto, Laura, et al.
Publicado: (2022)